The changes of in aqueous humor of different macular edema diseases in anti-VEGF treatment

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100046246

Enrollment

Unknown

Registered

2021-05-12

Start date

2021-05-12

Completion date

Unknown

Last updated

2021-12-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

macular edema diseases

Interventions

Ischemic optic neuropathy group:No

Branch vein occlusion group:No

Diabetic macular edema group:No

Age-related macular degeneration group:No

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1.Patients without any treatment; 2.Non uveitis patients; 3.Patients with definite diagnosis and anti VEGF treatment criteria.

Exclusion criteria

Exclusion criteria: Patients who have received anti VEGF or hormone therapy.

Design outcomes

Primary

Measure	Time frame
Vascular endothelial growth factor;Intercellular adhesion molecule-1;Tumor necrosis factors-a;Monocyte chemoattractant protein-1;Interleukin-6;	—

Countries

China

Contacts

Public ContactLi Na

Weifang Medical University

lina3588@sina.com+86 13863673855

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026